TETTAMANTI, SARAH
TETTAMANTI, SARAH
DIPARTIMENTO DI MEDICINA E CHIRURGIA (SCHOOL OF MEDICINE AND SURGERY)
CARs are sharpening their weapons
2024 Pievani, A; Biondi, M; Tettamanti, S; Biondi, A; Dotti, G; Serafini, M
Acute Myeloid Leukemia (AML) immunotherapy: development of TIM3-CD33 targeted Dual CAR CIK cells for eradication of LSCs in the bone marrow niche
2023 Arsuffi, C; Biondi, A; Tettamanti, S; Serafini, M
Engineering tandem CD33xCD146 CAR CIK (cytokine-induced killer) cells to target the acute myeloid leukemia niche
2023 Alberti, G; Arsuffi, C; Pievani, A; Salerno, D; Mantegazza, F; Dazzi, F; Biondi, A; Tettamanti, S; Serafini, M
IL3-zetakine combined with a CD33 costimulatory receptor as a Dual CAR approach for safer and selective targeting of AML
2023 Perriello, V; Rotiroti, M; Pisani, I; Galimberti, S; Alberti, G; Pianigiani, G; Ciaurro, V; Marra, A; Sabino, M; Tini, V; Spinozzi, G; Mezzasoma, F; Morena, F; Martino, S; Salerno, D; Ashby, J; Wingham, B; Serafini, M; Martelli, M; Falini, B; Biondi, A; Tettamanti, S
Overexpression of CXCR4 receptor on CD33.CAR-CIK cells enhances the control of the Acute Myeloid Leukemia burden
2023 Biondi, M; Tettamanti, S; Galimberti, S; Cerina, B; Tomasoni, C; Dotti, G; Biondi, A; Pievani, A; Serafini, M
Selective homing of CAR-CIK cells to the bone marrow niche enhances control of the Acute Myeloid Leukemia burden
2023 Biondi, M; Tettamanti, S; Galimberti, S; Cerina, B; Tomasoni, C; Piazza, R; Donsante, S; Bido, S; Maria Perriello, V; Broccoli, V; Doni, A; Dazzi, F; Mantovani, A; Dotti, G; Biondi, A; Pievani, A; Serafini, M
Catch me if you can: how AML and its niche escape immunotherapy
2022 Tettamanti, S; Pievani, A; Biondi, A; Dotti, G; Serafini, M
CXCR4-MODIFIED CD33.CAR-CIK WITH ENHANCED BONE MARROW HOMING IN ACUTE MYELOID LEUKEMIA
2022 Biondi, M; Cerina, B; Tomasoni, C; Dotti, G; Tettamanti, S; Biondi, A; Pievani, A; Serafini, M
Improving Bone Marrow Homing and Persistence of CD33.CAR-CIK Cells By Overexpression of a Gain-of-Function Variant of CXCR4 to Increase Efficacy in Acute Myeloid Leukemia
2022 Biondi, M; Cerina, B; Tomasoni, C; Dotti, G; Tettamanti, S; Biondi, A; Pievani, A; Serafini, M
Ingegnerizzazione di cellule CD33.CAR-CIK con una variante gain-of-function del recettore CXCR4 per aumentarne migrazione e persistenza nella nicchia midollare
2022 Biondi, M; Cerina, B; Tomasoni, C; Dotti, G; Tettamanti, S; Biondi, A; Pievani, A; Serafini, M
Optimization of therapeutic T cell expansion in G-Rex device and applicability to large-scale production for clinical use
2022 Gotti, E; Tettamanti, S; Zaninelli, S; Cuofano, C; Cattaneo, I; Rotiroti, M; Cribioli, S; Alzani, R; Rambaldi, A; Introna, M; Golay, J
Overexpression of CXCR4 Enhances the Efficacy of CAR-T Therapy for Acute Myeloid Leukemia
2022 Biondi, M; Galimberti, S; Cerina, B; Tomasoni, C; Dotti, G; Tettamanti, S; Biondi, A; Pievani, A; Serafini, M
Cellule CD33.CAR-CIK ingegnerizzate per co-esprimere il recettore CXCR4 al fine di aumentare la capacità di migrazione all’interno della nicchia midollare nella leucemia mieloide acuta
2021 Biondi, M; Cerina, B; Tomasoni, C; Dotti, G; Tettamanti, S; Biondi, A; Pievani, A; Serafini, M
Combining the expression of CD33.CAR and CXCR4 to augment CAR-CIKs homing to bone marrow niche and leukemic stem cell eradication in acute myeloid leukemia
2021 Biondi, M; Tomasoni, C; Dotti, G; Tettamanti, S; Biondi, A; Pievani, A; Serafini, M
Combining the Expression of CD33.CAR and CXCR4 to Increase CAR-CIK Cell Homing to Bone Marrow Niche and Leukemic Stem Cell Eradication in Acute Myeloid Leukemia
2021 Biondi, M; Cerina, B; Tomasoni, C; Dotti, G; Tettamanti, S; Biondi, A; Pievani, A; Serafini, M
Generation of CIK cells co-expressing CXCR4 and CD33.CAR with improved homing and antitumor activity for AML
2021 Biondi, M; Dotti, G; Biondi, A; Tettamanti, S; Pievani, A; Serafini, M
Sleeping Beauty-engineered CAR T cells achieve anti-leukemic activity without severe toxicities
2020 Magnani, C; Gaipa, G; Lussana, F; Belotti, D; Gritti, G; Napolitano, S; Matera, G; Cabiati, B; Buracchi, C; Borleri, G; Fazio, G; Zaninelli, S; Tettamanti, S; Cesana, S; Colombo, V; Quaroni, M; Cazzaniga, G; Rovelli, A; Biagi, E; Galimberti, S; Calabria, A; Benedicenti, F; Montini, E; Ferrari, S; Introna, M; Balduzzi, A; Valsecchi, M; Dastoli, G; Rambaldi, A; Biondi, A
Targeting CD33 in Chemoresistant AML Patient-Derived Xenografts by CAR-CIK Cells Modified with an Improved SB Transposon System
2020 Rotiroti, M; Buracchi, C; Arcangeli, S; Galimberti, S; Valsecchi, M; Perriello, V; Rasko, T; Alberti, G; Magnani, C; Cappuzzello, C; Lundberg, F; Pande, A; Dastoli, G; Introna, M; Serafini, M; Biagi, E; Izsvák, Z; Biondi, A; Tettamanti, S
Transposon-Based CAR T Cells in Acute Leukemias: Where are We Going?
2020 Magnani, C; Tettamanti, S; Alberti, G; Pisani, I; Biondi, A; Serafini, M; Gaipa, G
MALDI-MSI Pilot Study Highlights Glomerular Deposits of Macrophage Migration Inhibitory Factor (MIF) as a Possible Indicator of Response to Therapy in Membranous Nephropathy
2019 L'Imperio, V; Smith, A; Ajello, E; Piga, I; Stella, M; Denti, V; Tettamanti, S; Sinico, R; Pieruzzi, F; Garozzo, M; Vischini, G; Nebuloni, M; Pagni, F; Magni, F